Literature DB >> 21686539

Antipsychotic-drug-induced dilated cardiomyopathy.

Anil K Taneja1, Jonathan Wong, John Bayliss.   

Abstract

A man in his 30s presented with symptoms of shortness of breath (SOB). He was on clozapine for schizophrenic symptoms. From the initial two presentations it was thought to be and managed as a chest infection, and a perfusion ventilation scan was done to rule out pulmonary embolism. However, with worsening SOB on exertion, he presented for a third time, and was referred and seen in the Department of Medicine on this occasion. The ECG showed evidence of left atrial and ventricular enlargement. The chest x ray showed an increased cardiothoracic ratio. An urgent echocardiogram showed the presence of dilated cardiomyopathy with severe left ventricular systolic function impairment. The patient had a coronary angiogram and other relevant investigations to look for the cause of the dilated cardiomyopathy. These investigations did not reveal any significant abnormality. The cause appeared to be related to the drug clozapine. The patient was treated for heart failure, and clozapine was stopped. He improved and repeat echocardiogram at follow-up showed a definite improvement in the symptoms and the echocardiogram.

Entities:  

Year:  2009        PMID: 21686539      PMCID: PMC3029622          DOI: 10.1136/bcr.09.2008.0958

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Clozapine and sudden death.

Authors:  S Devarajan; S P Kutcher; S M Dursun
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

Review 2.  Adverse cardiac effects associated with clozapine.

Authors:  David B Merrill; G William Dec; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2005-02       Impact factor: 3.153

Review 3.  Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.

Authors:  P M Wehmeier; P Heiser; H Remschmidt
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

4.  Myocarditis and cardiomyopathy associated with clozapine.

Authors:  J G Kilian; K Kerr; C Lawrence; D S Celermajer
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

5.  Cardiomyopathy associated with clozapine.

Authors:  Sungwon Roh; Dong Hyun Ahn; Jung Hyun Nam; Byung Hwan Yang; Bang Hun Lee; Yang Suk Kim
Journal:  Exp Clin Psychopharmacol       Date:  2006-02       Impact factor: 3.157

Review 6.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  K Wahlbeck; M Cheine; M A Essali
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 7.  Atypical antipsychotic agents: a critical review.

Authors:  J A Worrel; P A Marken; S E Beckman; V L Ruehter
Journal:  Am J Health Syst Pharm       Date:  2000-02-01       Impact factor: 2.637

8.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Authors:  Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John Kane; Ranga Krishnan; J P Lindenmayer; Steven Potkin
Journal:  Arch Gen Psychiatry       Date:  2003-01
  8 in total
  1 in total

1.  Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia.

Authors:  Kenta Kawasaki; Kotaro Miyaji; Satoshi Kodera; Yoshio Suzuki; Junji Kanda; Masayuki Ikeda
Journal:  Clin Case Rep       Date:  2015-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.